The Community Oncology Alliance (COA) has submitted comments encouraging long-overdue Congressional reforms of the 340B Drug Pricing Program. In its response to a bipartisan United States Senate working group request for information (RFI) on the 340B program and SUSTAIN 340B Act discussion draft, COA continues its strong advocacy for reform of the program to realign it with its original intent of supporting vulnerable patients, especially those needing assistance in affording critical medications, such as cancer drugs. 

The Community Oncology Alliance (COA) is issuing an urgent call to action in response to the recent cyberattack on Change Healthcare that has had a catastrophic impact on the ability of independent, community oncology practices to treat patients.

The Community Oncology Alliance (COA) is pleased to announce the election of new and reappointed members to its Board of Directors and Executive Committee. COA is a non-profit singularly dedicated to advocating for independent, community oncology practices and, most importantly, the patients they serve.

Despite promising provisions in both rules, the proposed Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) rules for 2024 will continue the destructive trend of devaluing independent, community-based cancer care by paying them less than inflation and fueling the consolidation of independent providers into the more expensive hospital setting.